别名 靶点 EpCAM 作用机制 EpCAM调节剂(上皮细胞粘附分子调节剂) 治疗领域 肿瘤 在研适应症 晚期恶性实体瘤EpCAM阳性实体瘤肿瘤 非在研适应症- 原研机构 CytomX Therapeutics, Inc. 在研机构 CytomX Therapeutics, Inc. 非在研机构- 最高研发阶段临床1期 首次获批日期- 最高研发阶段(中国)- 特殊审评- ...
“CX-2051 is designed to address the unmet needs of patients with EpCAM-expressing tumors, including colorectal cancer, where EpCAM expression is uniformly high. EpCAM is a broadly expressed, validated anti-cancer target that to date has been limited in its development potential du...
“CX-2051 is designed to address the unmet needs of patients with EpCAM-expressing tumors, including colorectal cancer, where EpCAM expression is uniformly high. EpCAM is a broadly expressed, validated anti-cancer target that to date has been...